fraxinellone has been researched along with Glioblastoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Huang, C; Huang, Y; Huang, Z; Shi, J; Sun, S; Wang, Q; Wang, Y; Xing, S; Xue, X | 1 |
1 other study(ies) available for fraxinellone and Glioblastoma
| Article | Year |
|---|---|
Fraxinellone inhibits progression of glioblastoma via regulating the SIRT3 signaling pathway.
Topics: Adult; Animals; Apoptosis; Benzofurans; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Reactive Oxygen Species; Signal Transduction; Sirtuin 3 | 2022 |